Skip to content
Search

Latest Stories

GPhC considers annual monitoring of all pharmacy education providers

GPhC considers annual monitoring of all pharmacy education providers

The regulator proposes four key changes to the quality assurance of pharmacy education

The General Pharmaceutical Council (GPhC) has launched a consultation on changes to the quality assurance processes of pharmacy education and training.


In its consultation published on 4 April 2024, the pharmacy regulator has proposed four key changes to the procedures, including annual monitoring of all pharmacy education providers, including pharmacy schools offering MPharm courses.

The annual audit will enable the GPhC “to identify and address concerns together with providers in a more timely, proportionate and systematic manner”.

It is considering collecting yearly data, including feedback from students, trainees, supervisors and patients, from educational organisations.

The GPhC has also proposed defining clear lines of responsibility and criteria for determining whether to re-approve a course or qualification.

Other suggestions put forth include increasing flexibility for approval and intervention, alongside implementing uniform arrangements for all providers to achieve greater scrutiny.

The consultation states: “We propose to apply to private providers and pharmacist independent prescribing providers the same arrangements that apply to national awarding organisations and MPharm providers.

“In effect, this will result not only in greater scrutiny but in a consistent quality assurance approach overall.”

Mark Voce, chief strategy officer and deputy registrar at the GPhC, said: “Pharmacy education and training sets a foundation for the knowledge, skills, understanding and professional behaviours a pharmacy student must demonstrate in order to become fully qualified and join the professional register.

“As such it is vital that we check that training providers are meeting our standards through a quality assurance process. By doing this we are ensuring trainees are getting the right level of education to become competent practitioners of the future.”

He added that the proposed changes will help them “identify issues more effectively, act more quickly if necessary and be fairer to all providers.”

The QA process also ensures that pharmacists and pharmacy technicians joining the register are “skilled and knowledgeable, and that they demonstrate appropriate professional behaviours.”

Individuals and organisations with an interest in pharmacy education are being encouraged to take part in the consultation, which closes on 13 June 2024.

Depending on the outcome of the consultation, the regulator plans to implement these changes in stages over the coming years.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less